Regarding JV or BuyOut Speculation-Teva announced it will try to sell a line of their women's health business for 2 billion in an effort to reduce debt. Not sure if this is also to free up funds for a JV. Not sure that OWCP would value themselves that low even being pre-revenue and needing to go through clinical trials for prescription based products. Don't have the link but saw on Bloomburg this morning.